Sano Genetics, co-founded in 2017 by Charlotte Guzzo, Patrick Short, and William Jones at Cambridge University, offers a privacy-focused platform to facilitate patient involvement in medical research and clinical trials. The platform includes at-home genetic testing and supports research on various diseases like multiple sclerosis and Parkinson’s disease.Â
Sano’s mission involves advancing clinical operations in medicine, particularly as treatments become more targeted due to biomarker research. The company seeks to address the complexities of clinical trials by integrating genetic testing, recruitment, and long-term patient engagement into a single platform. This approach aims to streamline trial processes, potentially enhancing enrollment speed and facilitating research in personalized medicine. Sano focuses on accelerating clinical trials to improve patient care options in a rapidly evolving medical landscape.
Sano Genetics provides services suitable for individuals interested in participating in medical research and clinical trials. Their platform is mainly for people who want to contribute their genetic and medical information to aid in research for various health conditions. It includes individuals with specific health conditions seeking to contribute to research efforts in those areas. The platform makes it easier for these participants to engage in research activities from the comfort of their homes.
Sano offers genetic testing and counseling services tailored for clinical trials with a personalized medicine component. They provide at-home saliva DNA testing kits designed for ease and convenience, requiring less than ten minutes for self-administrating patients. The testing options available include whole exome, whole genome, single or multi-gene panels, and genotyping conducted in partnership with GxP/CLIA-CAP certified labs. Sano manages all aspects of this process, including logistics, patient support, and genetic counseling, while handling data generation, analytics, and reporting. Additionally, their at-home testing approach is cost-effective, potentially reducing expenses by up to 55% and alleviating the need for patients to visit a lab.
Also Read: 31 Frequently Asked Questions About DTC Genetic Testing
Sano’s approach in clinical trials is centered around patient engagement, emphasizing a streamlined patient journey. Their strategy includes designing studies focused on the patient experience and relevant outcomes. The process involves early-stage consultation and design optimization, with an understanding that early design adjustments can be more efficient and cost-effective compared to later stages, such as after protocol writing or trial launch. Sano provides expertise in refining study designs to enhance the overall patient experience in clinical trials.
Sano also creates tailored recruitment protocols and collaborates with clinical teams to strategize patient engagement through their platform. It includes screening, genetic testing, appropriate referrals, and ongoing patient interaction. Sano leverages its industry experience to assist in preparing the necessary documentation for ethics submissions. Their process is iterative and data-driven. It encompasses thorough management and evaluation at each step, aiming to enhance study delivery and reduce recruitment costs.
The team at Sano emphasizes the importance of thorough prescreening in identifying eligible patients for clinical trials. They focus on creating a pre-screener that is both detailed and straightforward. This aids in identifying the correct patients for each study. This prescreening process is integrated into the Sano Platform, enabling patients to assess their potential eligibility. Sano’s approach to prescreening aims to simplify the clinical trial process and enhance patient engagement, ultimately contributing to improved patient outcomes.
Consent is fundamental for ensuring patient education and empowerment in medical research. The Sano Platform incorporates digital consent, facilitating the collection and storage of participant consent efficiently. Sano’s approach to digital consent aligns with ethical and transparent research practices, streamlining the process. This feature is part of Sano’s broader effort to make the patient journey in medical research more seamless.
Check out the full list of their services here.
In the context of clinical trials, the process comes in three phases:
Sano Genetics offers pricing information upon request.
LifeDNA has emerged as a prominent option for analyzing 23andMe and many other raw data sources, owing to a combination of unique offerings and a commitment to personalized wellness.
We offer a basic DNA data analysis package to kickstart your journey. Users with raw data from 23andMe, AncestryDNA, etc., can access 194+ traits across interests such as Nutrition, Wellness, Vitamins and Supplements, Personality, Fitness, Sleep, Methylation, and Skincare.
Further, if you do not have raw DNA data, such as from 23andMe, LifeDNA provides that too. Start your personalized wellness journey with LifeDNA’s state-of-the-art DNA kits here.
Here is why many regard LifeDNA as the best option for making the most of your 23andMe, AncestryDNA, and other raw data:
*Understanding your genetics can offer valuable insights into your well-being, but it is not deterministic. Your traits can be influenced by the complex interplay involving nature, lifestyle, family history, and others.
Our reports have not been evaluated by the Food and Drug Administration. The contents on our website and our reports are for informational purposes only, and are not intended to diagnose any medical condition, replace the advice of a healthcare professional, or provide any medical advice, diagnosis, or treatment. Consult with a healthcare professional before making any major lifestyle changes or if you have any other concerns about your results. The testimonials featured may have used more than one LifeDNA or LifeDNA vendors’ product or reports.
